Please assess the completion status of the following clinical trial:

Trial Title: Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Histologically proven cervical cancer~* Squamous, Adenosquamous, Adeno carcinoma cell type~* International Federation of Gynecologic Oncology (FIGO) stage IIB - IVA~* Gynecologic Oncology Group (GOG) performance status 0 - 2~Exclusion Criteria:~* Previous history of chemotherapy or radiation~* History of other cancer~* Hypersensitivity to platinum agents~* Pregnancy~* Serious medical disease

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- weekly cisplatin (Type: ACTIVE_COMPARATOR): Weekly cisplatin 40mg/m2 during radiation therapy
- tri-weekly cisplatin (Type: EXPERIMENTAL): cisplatin 75mg/m2 three cycles, every 3 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).